Tipranavir

Back to search

Molecule Structure

Scientific Name

Tipranavir

Description of the Drug

Tipranavir is a protease inhibitor used to treat HIV-1 resistant to more than 1 protease inhibitor.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00932

Brand Name(s)

Aptivus

Company Owner(s)

Boehringer Ingelheim Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Human immunodeficiency virus type 1 protease SINGLE PROTEIN INHIBITOR CHEMBL243

Unichem Links

SureChEMBL SCHEMBL40629
WDI DR9606551
DrugBank DB00932
PubChem: Thomson Pharma 14813794 14813793
PubChem 54682461
Nikkaji J790.736B
PDBe TPV
BindingDB 50479982
EPA CompTox Dashboard DTXSID6048622
DrugCentral 3609
Brenda 2316
ChemicalBook CB9501005
GSRS 6e0e021c-7b42-4e74-8315-4a3d7b1fea80
rxnorm APTIVUS TIPRANAVIR
PubChem: Drugs of the Future 12015070
ChEBI 63628
ZINC ZINC000100016058